BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcomeMaria Grazia Tibiletti, Francesco Bertoni, Claudio Doglioni et al.|Human Pathology|2009Cited by 109
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphomaPaola Bonetti, Francesco Bertoni, Monica Testoni et al.|Blood|2013Cited by 70
Genomic lesions associated with a different clinical outcome in diffuse large B‐Cell lymphoma treated with R‐CHOP‐21Marta Scandurra, Francesco Bertoni, Michael Mian et al.|British Journal of Haematology|2010Cited by 52
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionMichael Mian, Francesco Bertoni, Marta Scandurra et al.|Annals of Oncology|2011Cited by 22
Subgroups of Diffuse Large B-Cell Lymphoma (DLBCL) with Different Genomic Lesions and Clinical Course During Treatment with R-CHOP.Marta Scandurra, Francesco Bertoni, Michael Mian et al.|Blood|2009Cited by 0